Skip to content

Public FDA record

Z-2367-2020: VITROS Chemistry Product Performance Verifier II, Product Code 8067324, UDI # 10758750004317 - Product Us

Recall record Z-2367-2020 for Ortho-Clinical Diagnostics. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2367-2020
Company in FDA record
Ortho-Clinical Diagnostics
FDA record creation date
Jun 15, 2020
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Multiple coatings of VITROS Chemistry Products AMYL Slides are showing imprecision on control fluids when compared to the expected within lab SD as listed on the Performance Verifier (PV) Assay Sheets.

Source facts

Action
On May 11, 2020, Ortho Clinical Diagnostics, Inc. sent an Urgent Medical Device Correction Notification to their customers alerting them of important information regarding the precision of VITROS AMYL Slides. The notice stated that the imprecision affects serum, urine and QC samples, however VITROS AMYL Slides performance continues to meet its intended clinical use. The VITROS Performance Verifiers I and II Control Assay Sheet estimated within-lab SD, Range of Means (ROM) and Delta table values were re-evaluated. The Delta tables will be updated in a future revision of the Performance Verifier Training Module. In the meantime, customers were instructed to use the revised estimated within-lab SD listed in the enclosed Information sheet to evaluate their lab's quality control when using VITROS Performance Verifier I and II products. When available on the Ortho website, https://www.orthoclinicaldiagnostics.com, customers can obtain the updated VITROS Performance Verifier Control Assay Sheets and can use the revised ROM to evaluate the labs VITROS AMYL Slide quality control when using VITROS Performance Verifier I and II products. The firm explained that a review of previously reported patient results is NOT recommended. The customers were asked to Complete the Confirmation of Receipt form no later than May 19, 2020 and to forward the notification if the product was distributed outside of their facility.
Initiated
2020-05-11
Root cause
Under Investigation by firm
Terminated
2021-09-22
Distribution
Worldwide distribution - US Nationwide including in the statesof Maine, Massachusetts, Vermont, Connecticut, New Jersey, New York, Pennsylvania, Washington DC, Maryland, Virginia, West Virginia, North Carolina, South Carolina, Georgia, Florida, Alabama, Tennessee, Missouri, Mississippi, Kentucky, Ohio, Indiana, Michigan, Iowa, Wisconsin, Minnesota, South Dakota, North Dakota, Montana, Illinois, Kansas, Nebraska, Louisiana, Arkansas, Oklahoma, Texas, Colorado, Idaho, Utah, Arizona, New Mexico, California, Hawaii, Oregon , Washington, and Alaska
Recall number
Z-2367-2020
Recall status
Terminated
CDRH record ID
181527
FDA record created
2020-06-15
Recall event number
85652

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗